홈 › 방광암 › 일리노이

일리노이의 방광암 임상 시험

방광암 관련 연구 30개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.

일리노이의 도시

공식 연구 텍스트(영어)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Rush MD Anderson Cancer Center, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
Carle at The Riverfront, Danville
외 12개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03866382

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Rush-Copley Medical Center, Aurora
OSF Saint Joseph Medical Center, Bloomington
Illinois CancerCare-Bloomington, Bloomington
외 38개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07061964

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06833073

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Memorial Hospital, Shiloh
Siteman Cancer Center - Shiloh, Shiloh

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07421700

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Northwestern Memorial Hospital, Chicago
Northwestern University - Feinberg School of Medicine, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07206225

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Chicago, Zion

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07277413

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Rush MD Anderson Cancer Center, Chicago
Carle at The Riverfront, Danville
Cancer Care Specialists of Illinois - Decatur, Decatur
외 11개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06770582

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

University of Illinois Cancer Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06172478

DESTINY-PANTUMOUR04

Research Site, Decatur

피험자 모집 중관찰 연구

18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

University of Illinois at Chicago, Chicago
University of Chicago Medical Center, Chicago
Endeavor Health, Evanston
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07218380

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Illinois Cancer Specialists, Niles

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07566156

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Chicago Hospital, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06465069

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Associated Urological Specialists, Chicago Ridge
Uropartners, Glenview
Accellacare, Lisle

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06567743

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
외 54개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

University of Chicago Medical Center ( Site 5037), Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT07232602

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Comprehensive Urologic Care, Lake Barrington

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05951179

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Research Site, Niles
Research Site, Peoria

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07129993

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

The University of Chicago Medical Center (UCMC), Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05614739

Measuring Surgical Recovery After Radical Cystectomy

University of Chicago, Chicago

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT03193970

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

OSF Saint Anthony's Health Center, Alton
OSF Saint Joseph Medical Center, Bloomington
Illinois CancerCare-Bloomington, Bloomington
외 32개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07097142

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Northwestern University, Chicago
University of Illinois, Chicago
Loyola University Medical Center, Maywood
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07000084

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

UChicago Medicine - River East, Chicago
University of Chicago Medical Center, Chicago
Accellacare - Deerfield, Deerfield
외 5개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT04879329

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ingalls Family Care Center, Calumet City
UChicago Medicine - River East, Chicago
The University Of Chicago, Chicago
외 13개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632

Integrated Cancer Repository for Cancer Research

Rush-Copley Cancer Care Center, Aurora
Rush-Copley Healthcare Center, Yorkville

피험자 모집 중관찰 연구건강한 지원자 환영

19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

Northwestern University, Chicago
Northwestern Medicine Orland Park, Orland Park

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 6. 12. 업데이트됨 · NCT06630416

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

The University of Chicago Comprehensive Cancer Center, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863

Blue Light Cystoscopy With Cysview® Registry

Northwestern University, Chicago
Northshore University Health System, Evanston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2025. 12. 18. 업데이트됨 · NCT02660645

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Chicago

피험자 모집 중관찰 연구

전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer

Jesse Brown Department Of Veterans Affairs Medical Center, Chicago

피험자 모집 중관찰 연구

18세 ~ 100세 · 모든 성별 · 2025. 10. 10. 업데이트됨 · NCT06310759

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

University of Chicago Medicine Comprehensive Cancer Center, Chicago

피험자 모집 중

65세 이상 · 모든 성별 · 2025. 10. 3. 업데이트됨 · NCT06427824

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.